Prenatal growth, BMI, and risk of type 2 diabetes by early midlife

Elina Hyppönen1, Chris Power, George Davey Smith

  • 1Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London, UK. e.hypponen@ich.ucl.ac.uk

Diabetes Care
|August 28, 2003
PubMed

Insights

Small size at birth does not increase type 2 diabetes risk if weight gain is normal. Adult obesity is the primary risk factor for developing type 2 diabetes by midlife.

Area of Science:

  • Epidemiology
  • Metabolic Health
  • Public Health

Background:

  • Small size at birth is linked to an increased risk of type 2 diabetes.
  • The impact of postnatal body mass accumulation on this association is not fully understood.

Purpose of the Study:

  • To investigate how body mass accumulation from childhood to adulthood modifies the risk of type 2 diabetes associated with low birth weight.

Main Methods:

  • Utilized data from the 1958 British birth cohort, tracking participants to age 41.
  • Assessed type 2 diabetes risk in relation to birth weight, childhood BMI, and weight gain trajectories.

Main Results:

  • Low birth weight was inversely associated with type 2 diabetes risk.
  • Excessive postnatal weight gain, particularly by age 23, was linked to increased diabetes risk, especially in those with low childhood BMI.
  • Adult obesity (BMI at 23 years) was a significant predictor of type 2 diabetes, with odds ratios of 22.9 for obesity and 3.8 for overweight individuals.

Conclusions:

  • The increased risk of type 2 diabetes associated with small birth size is mitigated by normal postnatal weight gain.
  • Adult obesity emerges as the most critical risk factor for developing type 2 diabetes by early midlife.
Abstract

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...